Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Design of Adverse Drug Events-Scorecards
View through CrossRef
This paper presents the design of Adverse Drug Event-Scorecards. The scorecards described are innovative and novel, not having previously been reported in the literature. The Scorecards provide organizations (e.g. hospitals) with summary information about Adverse Drug Events (ADEs) using a Web-based platform. The data used in the Scorecards are routinely updated and report on ADEs detected through data mining processes. The development of the ADE Scorecards is ongoing and they are currently undergoing clinical testing.
Title: Design of Adverse Drug Events-Scorecards
Description:
This paper presents the design of Adverse Drug Event-Scorecards.
The scorecards described are innovative and novel, not having previously been reported in the literature.
The Scorecards provide organizations (e.
g.
hospitals) with summary information about Adverse Drug Events (ADEs) using a Web-based platform.
The data used in the Scorecards are routinely updated and report on ADEs detected through data mining processes.
The development of the ADE Scorecards is ongoing and they are currently undergoing clinical testing.
Related Results
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
OBJECTIVES. The purposes of this study were to develop a pediatric-focused tool for adverse drug event detection and describe the incidence and characteristics of adverse drug even...
Studi Literatur Kasus Adverse Drug Reactions Dari Pengaruh Bahan Eksipien Obat
Studi Literatur Kasus Adverse Drug Reactions Dari Pengaruh Bahan Eksipien Obat
Abstract. Adverse Drug Reactions (ADRs) are generally triggered by active substances contained in the drugs used, but it is possible that these ADR events are caused and triggered ...
1010. Metronidazole-associated neurologic adverse events: risk factors analysis
1010. Metronidazole-associated neurologic adverse events: risk factors analysis
Abstract
Background
Metronidazole is a widely used antibiotic to treat anaerobic and protozoal infections. However, neurologic a...
Assessment of adverse events following vaccination with AstraZeneca Coronavirus Disease 2019 vaccine in Greater Kampala, Uganda, March-April 2021
Assessment of adverse events following vaccination with AstraZeneca Coronavirus Disease 2019 vaccine in Greater Kampala, Uganda, March-April 2021
Abstract
Background
Tracking of adverse events following vaccination is important for evaluating vaccine safety. During March 2021, Uganda began COVID-19 vaccination using...